Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACCEL-2C19: Cilostazol vs High-Dose Clopidogrel in PCI
NCT01012193Phase 4Completed
- Sponsor
- Gyeongsang National University Hospital
- Start
- Jan 2008
- Primary completion
- Jul 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of cilostazol in coronary artery disease (CAD), sponsored by Gyeongsang National University Hospital. Started Jan 2008; status: completed.
02
Drugs
cilostazol
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT01012193.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01012193.